Thomas A Waltz Net Worth & Insider Trades

Thomas A Waltz - Director, Peregrine Pharmaceuticals Inc

As of January 11, 2008

What is Thomas A Waltz's Net Worth?

The current estimated net worth of Peregrine Pharmaceuticals Inc's Director, Thomas A Waltz, is estimated to be about $3K . Thomas A Waltz owns about 2,500 units of Peregrine Pharmaceuticals Inc common stock. In the last 3 years at Peregrine Pharmaceuticals Inc, Thomas A Waltz has sold an estimated value of $0 worth.

What is Thomas A Waltz's Past Insider Trading?

Thomas A Waltz's largest purchase order was 2,500 units , worth over $3K on December 22, 2006. In total, Thomas A Waltz has made about 3 transactions over 3 years of their time at Peregrine Pharmaceuticals Inc. Thomas A Waltz usually trades in December, January and March, with the busiest year in 2006, 2008 and 2005.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Thomas A Waltz

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Thomas A Waltz's' Mailing Address?

  • Mailing address is 14272 Franklin Avenue, #100 Tustin CA 92780 CA

What are Peregrine Pharmaceuticals Inc's Past Insider Trades?

Peregrine Pharmaceuticals Inc's most recent insider trade came on October 27, 2017 by Mark R Bamforth who bought 50,000 units worth $225.09K . In the last 14 years, insiders at Peregrine Pharmaceuticals Inc have sold an estimated value of $694.76K and bought an estimated value of $1.84M worth of shares. Insider trading is most common in May, with the busiest year in 2012. The most active traders at the company are Eric S Swartz, Director,  Steven W King, President & CEO,  and Paul J Lytle, Chief Financial Officer .

PEREGRINE PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...